000 01366 a2200373 4500
005 20250516113044.0
264 0 _c20130702
008 201307s 0 0 eng d
022 _a1557-8852
024 7 _a10.1089/cbr.2012.1311
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aNie, Weiwei
245 0 0 _aThe bioinformatics analysis of miRNAs signatures differentially expressed in HER2(+) versus HER2(-) breast cancers.
_h[electronic resource]
260 _bCancer biotherapy & radiopharmaceuticals
_cFeb 2013
300 _a71-6 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aBiomarkers, Tumor
_xgenetics
650 0 4 _aBreast Neoplasms
_xgenetics
650 0 4 _aComputational Biology
650 0 4 _aFemale
650 0 4 _aGene Expression Profiling
650 0 4 _aGene Regulatory Networks
650 0 4 _aHumans
650 0 4 _aMicroRNAs
_xgenetics
650 0 4 _aOligonucleotide Array Sequence Analysis
650 0 4 _aReceptor, ErbB-2
_xmetabolism
650 0 4 _aSignal Transduction
700 1 _aJin, Lei
700 1 _aWang, Yanru
700 1 _aWang, Zexing
700 1 _aGuan, Xiaoxiang
773 0 _tCancer biotherapy & radiopharmaceuticals
_gvol. 28
_gno. 1
_gp. 71-6
856 4 0 _uhttps://doi.org/10.1089/cbr.2012.1311
_zAvailable from publisher's website
999 _c22133459
_d22133459